Apellis Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $9.1M | 417k | 21.88 |
| 2024-12-31 | $8.0M | 250k | 31.92 |
| 2024-09-30 | $351k | 12k | 28.83 |
| 2024-06-30 | $1.6M | 43k | 38.36 |
| 2024-03-31 | $26M | 441k | 58.78 |
| 2023-12-31 | $5.2M | 87k | 59.86 |
| 2023-09-30 | $6.7M | 177k | 38.05 |
| 2023-03-31 | $11M | 173k | 65.93 |
| 2022-12-31 | $6.8M | 132k | 51.71 |
| 2022-09-30 | $11M | 168k | 67.80 |
| 2021-12-31 | $5.7M | 120k | 47.28 |
| 2021-03-31 | $4.2M | 98k | 42.91 |
| 2020-12-31 | $5.4M | 95k | 57.20 |
| 2020-09-30 | $278k | 9.2k | 30.19 |
| 2020-06-30 | $2.2M | 68k | 32.66 |
| 2020-03-31 | $1.4M | 52k | 26.79 |
| 2019-12-31 | $2.5M | 81k | 30.62 |
| 2019-09-30 | $864k | 36k | 24.04 |
| 2019-06-30 | $1.2M | 47k | 25.33 |
| 2019-03-31 | $458k | 24k | 19.51 |
| 2018-12-31 | $672k | 51k | 13.20 |
| 2018-09-30 | $842k | 48k | 17.71 |
| 2018-06-30 | $599k | 27k | 22.00 |
| 2018-03-31 | $0 | 20 | 0.00 |
| 2017-12-31 | $26k | 1.2k | 21.28 |